Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate.

MLA

Reist, C. J., et al. “Astatine-211 Labeling of Internalizing Anti-EGFRvIII Monoclonal Antibody Using N-Succinimidyl 5-[211At]Astato-3-Pyridinecarboxylate.” Nuclear Medicine and Biology, vol. 26, no. 4, May 1999, pp. 405–11. EBSCOhost, https://doi.org/10.1016/s0969-8051(98)00120-6.

APA

Reist, C. J., Foulon, C. F., Alston, K., Bigner, D. D., & Zalutsky, M. R. (1999). Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate. Nuclear Medicine and Biology, 26(4), 405–411. https://doi.org/10.1016/s0969-8051(98)00120-6

Chicago

Reist, C J, C F Foulon, K Alston, D D Bigner, and M R Zalutsky. 1999. “Astatine-211 Labeling of Internalizing Anti-EGFRvIII Monoclonal Antibody Using N-Succinimidyl 5-[211At]Astato-3-Pyridinecarboxylate.” Nuclear Medicine and Biology 26 (4): 405–11. doi:10.1016/s0969-8051(98)00120-6.